Anticancer activities of several anthelminthics attracted considerable interest, especially their capacity to
target signal transduction pathways of CSCs / TICs of several tumor types.
SU101
targets the signal transduction activated by a messenger called platelet - derived growth factor, which controls the genes involved in tissue formation and wound healing.
Peter Parker of the Imperial Cancer Research Fund in London says he is delighted that a drug
targeting signal transduction is now in trials.
Not exact matches
During the early years of my PhD studies, I was very fascinated by the exciting discoveries in the field of
signal transduction, in particular how receptor tyrosine kinases are activated to transmit their
signals and how protein complexes are formed through defined protein folds (domains) interacting with specific cellular
targets.
Similarly, Bernaudin et al. [43] found increased expression of 18 genes in the neonatal rat brain following hypoxia (8 % O2 for 3 h) including several known hypoxia inducible genes such as MAP kinase phosphatase - 1 (MKP - 1), several HIF - 1
target genes including VEGF and GLUT - 1, genes implicated in apoptosis,
signal transduction molecules, and transcription factors.
Growth of osteosarcoma cells was inhibited by this drug by
targeting of multiple
signal transduction pathways [41].
Aside of the inhibition of
signal transduction, on -
target repositioning assumes that the
targets recognized in nematods, such as mitochondrial respiration and microtubules, are hit in cancer cells [70, 89, 90].
Furthermore, niclosamide inhibited not only
signal transduction, but also
targeted mitochondria in cancer cells resulting in cell cycle arrest, growth inhibition and apoptosis [49 - 51].
Cbl - b is an E3 ubiquitin ligase that
targets multiple components of the TCR
signal transduction pathway for degradation through the proteasome to facilitate termination of TCR
signaling (19, 20).
Recently, interest has developed regarding the possibility of
targeting intracellular inhibitory proteins to improve T cell activity against cancer, including diacylglycerol kinase ζ (DGKζ)(9, 10) and Casitas b - lineage proto - oncogene b (Cbl - b)(11), which attenuate
signal transduction events downstream of the TCR and CD28.